Elbasvir/grazoprevir

Details

Files

Generic Name:

Project Status:

Complete

Therapeutic Area:

Hepatitis C, chronic

Manufacturer:

Merck Canada Inc.

Call for patient/clinician input open:

September 23, 2015

Brand Name:

Zepatier

Project Line:

Reimbursement Review

Project Number:

SR0454-000

Call for patient/clinician input closed:

November 12, 2015

NOC Status at Filing:

Pre NOC

Performance Metric:

Achieved

Submission Type:

Initial

Indications:

Hepatitis C, chronic

Recommendation Type:

Reimburse with clinical criteria and/or conditions

Final Recommendation:

May 19, 2016

Last Updated : September 23, 2015